Table 1 Epidemiologic and clinical characteristics of patients admitted to the intensive care unit from 2005 to 2010
1a: Non-HIV versus all HIV patients | 1b: HIV versus HIV/HCV patients | |||||
|---|---|---|---|---|---|---|
Control group | All HIV group | P value | HIV group | HIV/HCV group | p-value | |
Number of patients | 7,496 | 1,891 | 1,191 (63%) | 700 (37%) | ||
Gender (male) | 5,827 (77.73%) | 1,466 (77.52%) | 0.869 | 911 (76.49%) | 555 (79.28%) | 0.177 |
Age (years) | 44 (36-49) | 43 (38-48) | 0.064 | 43 (38-50) | 43 (39-47) | 0.060 |
Abuse of alcohol and drugs | 2,453 (32.72%) | 942 (49.81%) | <0.001 | 494 (41.48%) | 448 (64.00%) | <0.001 |
Length of hospital stay (days) | 5 (1-25) | 7 (2-21) | <0.001 | 9 (2-25) | 5 (1-14) | <0.001 |
Conditions influencing health status | ||||||
Surgical conditions (V42, V45) | 302 (4.02%) | 80 (4.23%) | 0.740 | 53 (4.45%) | 27 (3.85%) | 0.616 |
Trauma (E880* to E929*, E950 to E999*) | 350 (4.66%) | 97 (5.12%) | 0.435 | 64 (5.37%) | 33 (4.71%) | 0.603 |
CHC-related comorbidities | ||||||
Chronic liver disease and cirrhosis | 851 (11.35%) | 248 (13.11%) | 0.036 | 106 (8.90%) | 203 (29.00%) | <0.001 |
Decompensated cirrhosis | 736 (9.82%) | 224 (11.85%) | 0.010 | 82 (6.88%) | 142 (20.29%) | <0.001 |
Liver cancer | 16 (0.21%) | 8 (0.42%) | 0.174 | 2 (0.17%) | 6 (0.86%) | 0.062 |
Liver transplant | 48 (0.64%) | 11 (0.58%) | 0.900 | 3 (0.25%) | 8 (1.14%) | 0.031 |
AIDS-related comorbidities | ||||||
Central nervous system disease | 31 (0.41%) | 24 (1.27%) | <0.001 | 15 (1.26%) | 9 (1.29%) | 1 |
Cancer | 73 (0.97%) | 91 (4.81%) | <0.001 | 72 (6.05%) | 19 (2.71%) | 0.002 |
Kaposi sarcoma | - | 27 (1.43%) | NA | 25 (2.10%) | 2 (0.29%) | 0.003 |
Non-Hodgkin lymphoma | 73 (0.97%) | 65 (3.44%) | <0.001 | 49 (4.11%) | 16 (2.29%) | 0.048 |
Wasting syndrome | 151 (2.01%) | 98 (5.18%) | <0.001 | 65 (5.46%) | 33 (4.71%) | 0.551 |